6 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Terminated 6 |
Follow ziprasidone: new trials by email Literature Review of ziprasidone trials Research Report on ziprasidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine Clozapine, Antipsychotics,Other (non-Clozapine) - Treatment-resistant Schizophrenia | Phase 4 | Terminated | Ohio State University | 5 | 2023-08-16 | 2026-02-25 |
| 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain Ziprasidone, aripiprazole, quetiapine, or risperidone - High Risk MC4R Genotype, Low Risk MC4R Genotype | Phase 4 | Terminated | Northwell Health | 14 | 2013-07-01 | 2016-02-05 |
| One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome Ziprasidone HCL (oral) - Schizophrenia and Disorders With Psychotic Features | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 172 | 2008-12-01 | 2021-03-03 |
| Ziprasidone And Olanzapine's Outcomes In Mania ziprasidone hydrochloride, olanzapine - Acute Mania, Bipolar Disorder, Manic | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 29 | 2006-11-01 | 2021-03-29 |
| Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder Ziprasidone, Placebo - Generalized Anxiety Disorder, Bipolar Disorder | Phase 4 | Terminated | Massachusetts General Hospital | 3 | 2006-02-01 | 2014-04-16 |
| 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients ziprazidone - Schizophrenia | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 150 | 2003-11-01 | 2021-02-21 |
Bipolar Disorder (2) · Schizophrenia (2) · Generalized Anxiety Disorder (1) · Metabolic Syndrome (1) · Psychotic Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Schizophrenia, Treatment-Resistant (1)
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (3) · Massachusetts General Hospital (1) · Northwell Health (1) · Ohio State University (1)
United States (3) · Canada (1) · Germany (1) · Greece (1) · Hungary (1) · Italy (1) · Spain (1) · Turkey (Türkiye) (1)